Miriam Merad1, 6, Petra Hoffmann2, 6, Erik Ranheim1, Sarah Slaymaker3, Markus G Manz1, 6, Sergio A Lira4, Israel Charo3, Donald N Cook5, Irving L Weissman1, Samuel Strober2
& Edgar G Engleman11
Department of Pathology, Stanford University School of Medicine Palo Alto, California
94304, USA.
2
Department of Medicine, Stanford University School of Medicine Palo Alto, California
94304, USA.
3
Cardiovascular Research Institute and the Department of Medicine, University of California, San Francisco, California
94104, USA.
4
Department of Immunobiology, Mount Sinai School of Medicine, New York, New York
10029-6574, USA.
5
Division of Pulmonary and Critical Care, Department of Medicine, Duke University Medical Center, Durham, North Carolina
27710, USA.
6
Present addresses: Carl C. Icahn Institute for Gene Therapy and Molecular Medicine, Mt. Sinai School of Medicine, New York, New York
10029, USA (M.M.); Department of Medicine, University of Regensburg, D-93053
Germany (P.H.); and Institute for Research in Biomedicine, 6500
Bellinzona, Switzerland (M.G.M.).
Correspondence should be addressed to Miriam Merad miriam.merad@mssm.edu
